Total raised
$18.5M
Last: Series F 2009-08
Stage
Mature
Founded
1996
Headcount
8
HQ
Netanya
Sector
Health Tech & Life Sciences
About
novoGi is focused on providing a range of solutions for GI disease management. Its proprietary technology facilitates natural healing with tissue-sparing, uniform BioDynamix anastomosis. The companys line of products utilizes nitinol-based elements to press together the ends of resected tissue, enabling a natural reconnection of the intestine after removing a section (e.g. for treatment of colon cancer).
Funding history · 1 round · $18.5M total
2009-08
Series F
$18.5M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
medical-devicescancersurgerymedical-technologiesgastroenterologytissue-regenerationdoctors